XEN 45 Glaucoma Treatment System - Glaucoma shunt

Access comprehensive regulatory information for XEN 45 Glaucoma Treatment System - Glaucoma shunt in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Abbvie Pty Ltd, manufactured by Allergan in United States of America. The device registration started on December 21, 2017.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.